Abstract 27P
Background
The objective of this study was to assess the effect of an educational activity on the knowledge of oncologists regarding the rationale for using next-generation antibody drug conjugates (ADCs) for the treatment of breast cancer and the latest data from clinical trials.
Methods
This CME activity consists of a 2000-word article presenting expert insights in an interview style. Effectiveness of this education was assessed with a repeated-pairs pre-/post-assessment study design using 3 knowledge questions and 1 confidence question, in which each individual served as their own control. A paired sample t-test assessed mean differences in average number of correct responses pre- to post-assessment, and a McNemar’s test assessed significant improvement at question level. P values <.05 are statistically significant. The activity launched on January 27, 2022, with data collected through to April 1, 2022.
Results
By June 22, 2022 this activity had reached 1,019 physicians of whom 375 were oncology specialists (41% from Europe, 22% from Asia, 21% from Middle East and North Africa, and 13% from Latin America). Sixty-seven oncologists who completed all assessment questions were included in the study analysis. The average knowledge of oncologists increased significantly from 45% pre to 77% post-education (P < .001) as assessed by correct responses to the knowledge questions. There was a significant improvement in the knowledge of the following learning objectives as shown in the table below. Table: 27P
Pre-activity mean % of responses correct | Post-activity mean % of responses correct | P value | |
The rationale for using next-generation ADCs to treat breast cancer | 57% | 82% | <.001 |
The latest data from clinical trials investigating next-generation ADCs for the treatment of breast cancer | 19% | 67% | <.001 |
There was a measurable improvement in confidence in around 55% of oncologists regarding understanding of the treatment implications of the latest clinical trial data, and a 71% average confidence shift for those whose confidence had improved.
Conclusions
This study showed a positive educational impact of a 2000-word article presenting expert insights in an interview style, on the latest developments regarding emerging ADCs for the treatment of breast cancer. Further education is needed to update physicians on new data and guideline recommendations as these evolve in the future
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Medscape.
Funding
The educational activity was supported by an independent educational grant from Daiichi Sankyo.
Disclosure
N. Dorkhom, D. Grainger, Y. Ren: Financial interests, Personal, Full or part-time Employment: Medscape.
Resources from the same session
6P - Deep learning radiomics supports perioperative treatment decisions and is associated with LncRNAs in breast cancer: A multicenter study
Presenter: Yunfang Yu
Session: Poster viewing 01
7P - Predicting lymph node metastasis and molecular subtype from pathology united with genomics in breast cancer with multitask deep learning
Presenter: Zehua Wang
Session: Poster viewing 01
8P - Dismantling the role of liquid biopsy in predicting outcome of patients with early-stage breast cancer following neoadjuvant therapy: A systematic review
Presenter: Jeremiah Wijaya
Session: Poster viewing 01
9P - Development and validation of a pathogenomics model to improve the risk stratification of breast cancer: A deep learning study
Presenter: lin ruichong
Session: Poster viewing 01
10P - Enriched gut microbiota increases anticancer drug efficacy in breast cancer cell lines: A promising in vitro approach
Presenter: Selvaraj Jayaraman
Session: Poster viewing 01
11P - Preservation of intercostobrachial nerve during axillary lymph node dissection in breast cancer patients positively impacts chronic pain, sensory changes, and quality of life: Should it be the standard?
Presenter: Ajai Sasidhar
Session: Poster viewing 01
12P - Non-clinical factors influencing patient’s choice of mastectomy over breast conservation among Indian women with breast cancer
Presenter: Nivedita Sharma
Session: Poster viewing 01
13P - Hypofractionated radiotherapy in post operative breast cancer patients: 3-year clinical experience in a newly established cancer center
Presenter: Shaila Sharmin
Session: Poster viewing 01
14P - The impact of the deep inspiration breath-hold (DIBH) technique in the heart and other organ-at-risk (OAR) dose sparing in the postoperative radiotherapy to the left early breast cancer
Presenter: Hui-Ling Yeh
Session: Poster viewing 01
15P - Delays in breast cancer treatment in a tertiary hospital
Presenter: Rogelio Velasco
Session: Poster viewing 01